ClinicalTrials.Veeva

Menu

The Effect of COVID-19 on Diabetes Mellitus (COVID-19-DM)

U

Uşak University

Status

Unknown

Conditions

Diabetes Mellitus
Covid19

Study type

Observational

Funder types

Other

Identifiers

NCT04592055
UU-DM002

Details and patient eligibility

About

The study aimed to evaluate the effect of SARS-COV-2 infection on metabolic status in patients with diabetes mellitus. Patients' HbA1c levels before and after SARS-COV-2 infection will be evaluated.

Full description

In this time pediods, all patients with RT-PCR positive for SARS-COV-2 will be analysed for the presence of diabetes mellitus. Previous HbA1c levels will be obtained from hospital records. In these patients, previous A1c levels and A1c levels 3 months after the SARS-COV-2 infection will be compared.

Enrollment

500 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All hospitalised diabetic patients with RT-PCR- positive for SARS-COV-2 will be enrolled.

Exclusion criteria

  • The absence of diabetes mellitus RT-PCR- negative for SARS-COV-2 Non-hospitalised patients

Trial contacts and locations

1

Loading...

Central trial contact

Cevdet Duran

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems